Can a Platelet-Boosting drug speed recovery in kids with neuroblastoma?
NCT ID NCT06818916
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This trial tests whether hetrombopag, a drug that stimulates platelet production, can help children with neuroblastoma recover their platelets faster after a stem cell transplant. Thirty children will take the drug daily for up to 6 weeks. The main goal is to see if it increases the rate of platelet engraftment, which could reduce the need for platelet transfusions.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Hetrombopag (a drug that stimulates platelet production)
What this could lead to
If it works, this could offer a way to speed up platelet recovery after stem cell transplant, reducing the need for transfusions in children with neuroblastoma.
What could go wrong
This is a small, early-phase trial with only 30 children, so results may not apply broadly. The drug may not improve platelet engraftment or could cause side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEUROBLASTOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Department of Stem Cell Transplantation, Beijing Children's Hospital, Capital Medical University
RECRUITINGBeijing, China
Contact Phone: •••-•••-•••• Email: •••••@•••••